Clinical Trials Browser

Completed × Pleural Effusion, Malignant × Bevacizumab × Clear all

NCT02054052 2019-03-29

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung, Pericardial Effusion, Pleural Effusion, Malignant

NCT00533585 2016-02-10

BAY 43-9006 in Previously Untreated Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase 1 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

NCT01661790 2015-03-25

Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer

Phase 3 Completed

72 enrolled 5 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant

NCT00343291 2011-06-07

A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Phase 2 Completed

121 enrolled 16 charts

Carcinoma, Non-Small-Cell Lung, Pleural Effusion, Malignant